Haleon is the result of the combination of three consumer healthcare businesses, GSK, Novartis and Pfizer, over the last decade. While Haleon is still a young company, some of our brands have over 170 years’ worth of history. The early foundations to what Haleon is today originated in a single apothecary shop in London, opened in 1715 by Silvanus Bevan. Over the centuries our legacy companies have been founded, grown, acquired and merged, leading to the creation of Haleon which has one purpose – to deliver better everyday health with humanity.

With the demerger of consumer healthcare business from GSK group, Haleon plc was formed as an independent listed company and was listed on London Stock Exchange and New York Stock Exchange on 18 July 2022 and 20 July 2022, respectively. Haleon Pakistan was already listed on Pakistan Stock Exchange, before the demerger, as GlaxoSmithKline Consumer Healthcare Pakistan Limited and underwent a change of name to reflect the change of group to Haleon in Pakistan. For more information on the demerger, please visit https://www.haleon.com/investors/demerger-information. For more information on Haleon Pakistan, please visit our Investors page.

design asset